Ten-Year and Beyond Follow-up After Treatment With Highly Purified Liquid-Injectable Silicone for HIV-Associated Facial Lipoatrophy: A Report of 164 Patients

• Published in: Dermatologic surgery Vol. 45; no. 7; p. 941
• Main Authors: Jones, Derek H, Carruthers, Alastair, Brody, Harold J, Black, Jeanette M, Humphrey, Shannon, Carruthers, Jean, Wesley, Naissan O, Minokadeh, Ardalan
• Format: Journal Article
• Language: English
• Published: United States 01.07.2019
• Subjects: Biocompatible Materials - administration & dosage; Cohort Studies; Cosmetic Techniques; Dimethylpolysiloxanes - administration & dosage; Facial Dermatoses - therapy; Follow-Up Studies; HIV-Associated Lipodystrophy Syndrome - therapy; Humans; Injections, Subcutaneous; Male; Silicones - administration & dosage; Time Factors

Highly purified liquid-injectable silicone (LIS) has been established as a permanent agent for off-label correction of HIV-associated facial lipoatrophy (HIV-FLA). However, controversy exists about long-term safety. To establish the safety and efficacy at 10 years or greater of LIS for HIV-FLA. Pati...